International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.
about
Effects of first and second generation antihistamines on muscarinic induced mucus gland cell ion transportLeveraging the cortical cholinergic system to enhance attentionCharacterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviorsCholinergic filtering in the recurrent excitatory microcircuit of cortical layer 4.Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical veinActivation of muscarinic acetylcholine receptors elicits pigment granule dispersion in retinal pigment epithelium isolated from bluegillActivation of the SPHK/S1P signalling pathway is coupled to muscarinic receptor-dependent regulation of peripheral airwaysAn update on the use of transdermal oxybutynin in the management of overactive bladder disorderRegulation of urinary bladder function by protein kinase C in physiology and pathophysiologyEfficacy and safety of muscarinic antagonists as add-on therapy for male lower urinary tract symptomsDistribution and effects of the muscarinic receptor subtypes in the primary visual cortexThe pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder diseaseBoosting visual cortex function and plasticity with acetylcholine to enhance visual perception.Autonomic nervous system and immune system interactionsAge-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progressionStructure and dynamics of the M3 muscarinic acetylcholine receptorAlzheimer's disease: Targeting the Cholinergic SystemDiscovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probeDiscovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)Regulation of a G protein-gated inwardly rectifying K+ channel by a Ca(2+)-independent protein kinase CMuscarinic activation of inwardly rectifying K(+) conductance reduces EPSPs in rat hippocampal CA1 pyramidal cellsAnalysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-aminesMultiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtypeNeural transcriptome reveals molecular mechanisms for temporal control of vocalization across multiple timescalesTRPC Channels Mediate a Muscarinic Receptor-Induced Afterdepolarization in Cerebral Cortex.Knockouts reveal overlapping functions of M(2) and M(4) muscarinic receptors and evidence for a local glutamatergic circuit within the laterodorsal tegmental nucleus.Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).The efferent medial olivocochlear-hair cell synapse.The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamideBeyond the dopamine receptor: novel therapeutic targets for treating schizophrenia.Long-term effects of methamphetamine exposure on cognitive function and muscarinic acetylcholine receptor levels in mice.A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairmentM1 muscarinic receptor for the development of auditory cortical function.Neurochemistry of the afferents to the rat cochlear root nucleus: possible synaptic modulation of the acoustic startle.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsFormation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single moleculesHippocampal Gαq/₁₁ but not Gαo-coupled receptors are altered in aging.Using Extracellular Single-unit Electrophysiological Data as a Substrate for Investigative Laboratory Exercises.Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.
P2860
Q21262025-930D7B1B-BA8E-46FE-AF42-E1BB05E008F5Q24598925-BCEC080B-9FFA-453B-81BA-9D04B8F65133Q24645178-525B42F8-7A30-47B0-ADCC-A3EC47E1DB82Q24645678-F0D3DAE9-EEBD-45E0-818E-65C926BF3D6FQ24648779-D6139207-700F-48E5-AF1E-5894C697C9CDQ24671835-D9527691-2F37-460A-93B2-A0E6E6888D75Q24796215-C835D3F6-AA25-41EE-933C-D91570EE61D6Q24811637-BAFC764D-1116-43C5-BC3E-88F38CFBA776Q26749105-3AB88216-458C-4F1E-B78E-369481E7567BQ26780063-075B131B-20BF-4F94-A491-91789F833FC8Q26825032-10AC8456-95DF-415B-A0C3-9A2D4BC1B694Q26851426-3CF46FE0-F629-42A2-8A2F-D19A25C30E95Q26864937-5AA80937-9AC5-4423-B6E2-AA57EA235C6AQ26998400-3A33F1BD-93DC-4966-B6F1-CF90EFE3D8EEQ27026889-6B1C61EE-C31B-45DC-8E08-E738AEA10780Q27027373-B011D22F-17C7-4E6F-B9D3-E89FB1A54B74Q27677433-B940A3DC-FD21-45C2-994C-4009A7D5819AQ28070135-1450FA2F-EC2F-4A11-B6AE-79C8697C74CCQ28237300-C8291F38-9E4D-43F1-8416-97495A3267E6Q28300950-04F0670E-4023-4F07-B246-96ED0A325746Q28344010-F2E0022A-96CC-4555-9850-F70F403BFB43Q28348754-EC153D02-CFF7-4057-AB0C-2A88548FA02AQ28354168-1E8D374A-2054-45A1-BB6D-4D0163B95A71Q28591691-5AB3E056-9F77-45CA-ADA6-D7E38F08896FQ28646984-7AAAAAD5-7FEC-4650-AF95-B8A92C7844FBQ30437078-D4280A10-9ECE-4C24-BB51-6E09267C9E7EQ30447164-8CF07FF7-C4B1-4B4C-8BC3-7BD859949775Q30457688-9FB78A8A-6F39-41EE-BBB6-D013D4E37EDDQ30459574-25872BA6-FE0C-4260-9548-2632409D3629Q30462810-A9931700-7E44-41E4-ABA6-19A20C005E92Q30473410-813A6BAF-1807-418B-964C-950B060E5A1EQ30473882-2FEEBBCB-5E19-4CE9-9682-F2848989D758Q30475205-7A60AFEF-47E4-4DB3-A490-4C3D8158DA06Q30478791-F3F97304-F8D1-40F9-BFE5-D9670F219C6AQ30482892-D41BD33C-512C-4962-AE72-0324840D8819Q30486707-9ADC44E2-B3B7-4DBF-9DB5-0C5E489F5AEAQ30493203-4288FD47-BCC1-4661-BECF-2B6C901C0743Q30541270-95DFEE19-A881-4F3E-943D-8A15005E40E6Q30598677-5D16B830-150D-4A4D-8846-50CE9CA539D0Q33224958-49F0AA33-9F7B-4C21-8C9F-9A26FF3BA451
P2860
International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
International Union of Pharmac ...... rinic acetylcholine receptors.
@en
International Union of Pharmac ...... rinic acetylcholine receptors.
@nl
type
label
International Union of Pharmac ...... rinic acetylcholine receptors.
@en
International Union of Pharmac ...... rinic acetylcholine receptors.
@nl
prefLabel
International Union of Pharmac ...... rinic acetylcholine receptors.
@en
International Union of Pharmac ...... rinic acetylcholine receptors.
@nl
P1476
International Union of Pharmac ...... arinic acetylcholine receptors
@en
P2093
Birdsall NJ
Caulfield MP
P304
P577
1998-06-01T00:00:00Z